BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8761187)

  • 1. Raynaud's phenomenon in rheumatoid arthritis.
    Saraux A; Allain J; Guedes C; Baron D; Youinou P; Le Goff P
    Br J Rheumatol; 1996 Aug; 35(8):752-4. PubMed ID: 8761187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon in rheumatoid arthritis.
    Grassi W; Blasetti P; Core P; Cervini C
    Br J Rheumatol; 1994 Feb; 33(2):139-41. PubMed ID: 8162478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of Raynaud's syndrome in rheumatoid arthritis.
    Carroll GJ; Withers K; Bayliss CE
    Ann Rheum Dis; 1981 Dec; 40(6):567-70. PubMed ID: 7332376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
    Mueller M; Gschwandtner ME; Gamper J; Giurgea GA; Kiener HP; Perkmann T; Koppensteiner R; Schlager O
    J Intern Med; 2018 Mar; 283(3):293-302. PubMed ID: 29068146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Raynaud's phenomenon and migraine in a random population of hospital employees.
    O'Keeffe ST; Tsapatsaris NP; Beetham WP
    J Rheumatol; 1993 Jul; 20(7):1187-8. PubMed ID: 8371215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
    Kahan A; Amor B; Menkes CJ
    Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of Raynaud's phenomenon in individuals not using vibrating tools].
    Iwata H; Makimo S; Miyashita K
    Sangyo Igaku; 1987 Nov; 29(6):500-3. PubMed ID: 3448316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients.
    Kobak S
    Clin Rheumatol; 2011 Jun; 30(6):843-7. PubMed ID: 21243388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.
    Jinnin M; Ihn H; Yamane K; Asano Y; Yazawa N; Tamaki K
    Clin Exp Rheumatol; 2003; 21(1):91-4. PubMed ID: 12673896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporal relationship of Raynaud's phenomenon and features of connective tissue disease in rheumatoid arthritis.
    Pope JE; Al-Bishri J; Al-Azem H; Ouimet JM
    J Rheumatol; 2008 Dec; 35(12):2329-33. PubMed ID: 18843783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey.
    Calgüneri M; Ureten K; Akif Oztürk M; Onat AM; Ertenli I; Kiraz S; Akdogan A
    Clin Exp Rheumatol; 2006; 24(3):305-8. PubMed ID: 16870099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
    Caccavo D; Del Porto F; Garzia P; Mitterhofer AP; Galluzzo S; Rigon A; Vadacca M; Navajas MF; Amoroso A; Afeltra A
    Ann Rheum Dis; 2003 Oct; 62(10):1003-5. PubMed ID: 12972482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does prevalence of migraine and Raynaud's phenomenon also increase in Korean patients with proven variant angina?
    Koh KK; Kim SH; Lee KH; Kwon KS; Kim EJ; Baik SH; Cho SK; Kim SS; Park CO; Chung JK
    Int J Cardiol; 1995 Aug; 51(1):37-46. PubMed ID: 8522395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's phenomenon: pathogenesis and prevalence].
    Mikulska D
    Ann Acad Med Stetin; 2010; 56(1):11-4. PubMed ID: 21427808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.
    Planchon B; Pistorius MA; Beurrier P; De Faucal P
    Angiology; 1994 Aug; 45(8):677-86. PubMed ID: 8048777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud's phenomenon in idiopathic carpal tunnel syndrome.
    Pal B; Keenan J; Misra HN; Moussa K; Morris J
    Scand J Rheumatol; 1996; 25(3):143-5. PubMed ID: 8668956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
    Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
    Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.